SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-006772
Filing Date
2021-02-16
Accepted
2021-02-16 20:15:22
Documents
1
Period of Report
2021-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7797
  Complete submission text file 0000899243-21-006772.txt   9119
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address
Robb Gary Charles (Reporting) CIK: 0001529655 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50679 | Film No.: 21642094